Related Experiment Video
Updated: Jul 18, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Management of papillary microcarcinoma of the thyroid
1Department of Internal Medicine, Stanford School of Medicine, University of South Dakota, Rapid City, USA.
Abstract:
Papillary carcinoma of the thyroid is usually an indolent tumor with a good survival prognosis especially when small and limited to the thyroid gland. The prevalence of this tumor in younger patients with long life expectancies, however, magnifies the problem of late recurrences. Current published guidelines recommend near total thyroidectomy for all differentiated thyroid cancers with the exception of small papillary carcinomas (< 1.0 cm) found coincidentally after surgery for benign disease, providing there are no other risk factors. Presentation of completion thyroidectomy as an option to the patient is recommended. Both the patient and physician should be aware that 15-20% of cases will have another focus in the contralateral lobe and that long-term recurrent disease may reach 20% or more in the absence of complete resection. Despite their small size, 5% or more of these tumors may be associated with invasion of the capsule or distant metastases (Stage III or IV). The task for patient and physician is to fairly balance these factors against the risks and cost of the additional procedures.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
